188 related articles for article (PubMed ID: 35761163)
1. Near Elimination of In Vitro Predicted Extrathoracic Aerosol Deposition in Children Using a Spray-Dried Antibiotic Formulation and Pediatric Air-Jet DPI.
Farkas D; Thomas ML; Hassan A; Bonasera S; Hindle M; Longest W
Pharm Res; 2023 May; 40(5):1193-1207. PubMed ID: 35761163
[TBL] [Abstract][Full Text] [Related]
2. Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface.
Farkas D; Bonasera S; Bass K; Hindle M; Longest PW
Pharm Res; 2020 Aug; 37(9):177. PubMed ID: 32862295
[TBL] [Abstract][Full Text] [Related]
3.
Howe C; Momin MAM; Bass K; Aladwani G; Bonasera S; Hindle M; Longest PW
J Aerosol Med Pulm Drug Deliv; 2022 Aug; 35(4):196-211. PubMed ID: 35166601
[No Abstract] [Full Text] [Related]
4. Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.
Longest PW; Golshahi L; Behara SR; Tian G; Farkas DR; Hindle M
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):189-201. PubMed ID: 25192072
[TBL] [Abstract][Full Text] [Related]
5. Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.
Longest W; Hassan A; Farkas D; Hindle M
Pharm Res; 2022 Feb; 39(2):295-316. PubMed ID: 35147870
[TBL] [Abstract][Full Text] [Related]
6. Development of Dry Powder Inhaler Patient Interfaces for Improved Aerosol Delivery to Children.
Bass K; Longest W
AAPS PharmSciTech; 2020 May; 21(5):157. PubMed ID: 32451773
[TBL] [Abstract][Full Text] [Related]
7. Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.
Farkas D; Hindle M; Bonasera S; Bass K; Longest W
J Aerosol Med Pulm Drug Deliv; 2020 Apr; 33(2):83-98. PubMed ID: 31464559
[No Abstract] [Full Text] [Related]
8. Advancement of the Infant Air-Jet Dry Powder Inhaler (DPI): Evaluation of Different Positive-Pressure Air Sources and Flow Rates.
Howe C; Momin MAM; Farkas DR; Bonasera S; Hindle M; Longest PW
Pharm Res; 2021 Sep; 38(9):1615-1632. PubMed ID: 34462876
[TBL] [Abstract][Full Text] [Related]
9. Development of a High-Dose Infant Air-Jet Dry Powder Inhaler (DPI) with Passive Cyclic Loading of the Formulation.
Howe C; Momin MAM; Aladwani G; Hindle M; Longest PW
Pharm Res; 2022 Dec; 39(12):3317-3330. PubMed ID: 36253630
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler.
Bass K; Farkas D; Longest W
AAPS PharmSciTech; 2019 Nov; 20(8):329. PubMed ID: 31676991
[TBL] [Abstract][Full Text] [Related]
11. Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.
Howe C; Hindle M; Bonasera S; Rani V; Longest PW
J Aerosol Med Pulm Drug Deliv; 2021 Feb; 34(1):57-70. PubMed ID: 32758026
[No Abstract] [Full Text] [Related]
12. Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model.
Bass K; Momin MAM; Howe C; Aladwani G; Strickler S; Kolanjiyil AV; Hindle M; DiBlasi RM; Longest W
AAPS PharmSciTech; 2022 Apr; 23(5):114. PubMed ID: 35441324
[TBL] [Abstract][Full Text] [Related]
13. New Air-Jet Dry Powder Insufflator for High-Efficiency Aerosol Delivery to Rats.
Pangeni R; Hassan AAM; Farkas D; Sudarjat H; Longest W; Hindle M; Xu Q
Mol Pharm; 2023 Apr; 20(4):2207-2216. PubMed ID: 36938947
[TBL] [Abstract][Full Text] [Related]
14. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
Hassan A; Farkas D; Longest W; Hindle M
Int J Pharm; 2020 Dec; 591():120027. PubMed ID: 33130220
[TBL] [Abstract][Full Text] [Related]
15. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
Son YJ; Worth Longest P; Hindle M
Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343
[TBL] [Abstract][Full Text] [Related]
16. Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations.
Boc S; Momin MAM; Farkas DR; Longest W; Hindle M
AAPS PharmSciTech; 2021 Apr; 22(4):135. PubMed ID: 33860378
[TBL] [Abstract][Full Text] [Related]
17. Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome.
Boc S; Momin MAM; Farkas DR; Longest W; Hindle M
AAPS PharmSciTech; 2021 Apr; 22(4):136. PubMed ID: 33860409
[TBL] [Abstract][Full Text] [Related]
18. Advancement of a high-dose infant air-jet dry powder inhaler (DPI) with passive cyclic loading: Performance tuning for different formulations.
Howe C; Momin MAM; Aladwani G; Strickler S; Hindle M; Longest W
Int J Pharm; 2023 Aug; 643():123199. PubMed ID: 37406945
[TBL] [Abstract][Full Text] [Related]
19. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.
Farkas DR; Hindle M; Longest PW
Ann Biomed Eng; 2015 Nov; 43(11):2804-15. PubMed ID: 25986955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
